Senior Principal
IQVIA
Watertown, MA
Rory uses advanced analytics to create innovative Gross to Net strategies and solutions to help manufacturers accelerate portfolio growth. He has been an invited speaker at the FDA's Center for Drug Evaluation and Research (CDER) and is the author of several texts on machine learning and statistical analysis. His published studies of the 340B drug discount program help shed light on how the program works, potential problem areas, and how it is evolving.
Disclosure information not submitted.
Thursday, October 19, 2023
8:30 AM – 9:45 AM East Coast USA Time